NOVARTIS Announces Quarterly Results (4QFY18); Net Profit Up 809.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 25th May, 2020 on account of Id-Ul-Fitr (Ramzan Id).

NOVARTIS Announces Quarterly Results (4QFY18); Net Profit Up 809.6%
Fri, 20 Jul

NOVARTIS has announced its results for the quarter ended March 2018. Here is a detailed performance review of the same:

NOVARTIS Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-17*
3
Dec-17*
3
Mar-18*
QoQ ChangeYoY Change
Net SalesRs m1,4551,5611,253-19.7%-13.9%
Other incomeRs m1481451,096658.5%640.0%
TurnoverRs m1,6031,7062,34937.7%46.6%
ExpensesRs m1,5141,4431,4722.0%-2.8%
Gross profitRs m-59118-219-285.3%
DepreciationRs m135618.5%-52.2%
InterestRs m43511506.3%1217.9%
Profit before taxRs m72254819222.4%1044.1%
TaxRs m4367555731.3%1204.7%
Profit after taxRs m2918726541.2%809.6%
Gross profit margin%-4.17.6-17.5
Effective tax rate%59.426.267.7
Net profit margin%1.811.011.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 13.9% on a year-on-year (YoY) basis. The expenses were down by 2.8% YoY during the same period.
  • The company's operating profit increased by 269.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 17.5% in 4QFY18 as against 4.1% in 4QFY17.
  • Depreciation charges and finance costs declined by 52.2% YoY and 1217.9% YoY, respectively.
  • Other income increased by 640.0% YoY during the quarter.
  • Net profit for the quarter increased by 809.6% YoY. Net profit margins during the quarter increased from 1.8% in 4QFY17 to 11.3% in 4QFY18.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 19.7% on a quarter-on-quarter (QoQ) basis. The expenses were up by 2.0% QoQ during the same period.
  • The company's operating profit declined by 285.3% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 17.5% in 4QFY18 as against 7.6% in 3QFY17.
  • Net profit for the quarter increased by 41.2% QoQ, while net profit margins same from 11.0% in 3QFY17 to 11.3% in 4QFY18.

To see how NOVARTIS has performed over the last eight quarters, please visit here.

NOVARTIS Share Price Performance

Over the last one year, NOVARTIS share price has moved up from Rs 637.8 to Rs 625.0, registering a Loss of Rs -12.9 or around 2.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,620.9 (up 0.8%). Over the last one year it has moved down from 14,918.1 to 13,620.9, a gain of -1,297.3 points (down 8.7%).

Overall, the S&P BSE SENSEX is up 0.4% over the year.

Current Valuations

At the current price of Rs 625.0, the price to earnings (P/E) ratio of NOVARTIS stands at 267.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 28.6 times.

Equitymaster requests your view! Post a comment on "NOVARTIS Announces Quarterly Results (4QFY18); Net Profit Up 809.6%". Click here!

  

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Protect Your Wealth from Fund Managers(Fast Profits Daily)

May 14, 2020

Do you know how much you are paying in fees to your mutual fund? In this video I'll share with you my views.

Covid-19 Offers a Rare Opportunity to Own This Brand Leader(Profit Hunter)

May 12, 2020

Covid-19 has compounded uncertainties in investing but this smallcap company is strong enough to survive and even emerge stronger.

Of India's 20 Trillion Stimulus Package and the Swoosh Index for a Swoosh Recovery(Profit Hunter)

May 13, 2020

For India's rapid economic recovery, hopping on to the Swoosh index is a must.

How Commodity Prices Tell You When Stocks Will Go Up(Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

Why Buffet - and you - should study Quantum Liquid Fund(The Honest Truth)

May 14, 2020

Ajit Dayal on how Quantum Liquid Fund and Warren Buffett have similar investing styles.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


May 22, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - TEVA PHARMA COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS